Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073727 | SCV001239286 | uncertain significance | Retinal dystrophy | 2017-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003736970 | SCV004553682 | uncertain significance | not provided | 2022-11-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). ClinVar contains an entry for this variant (Variation ID: 866030). This variant has not been reported in the literature in individuals affected with IMPDH1-related conditions. This variant is present in population databases (rs144929093, gnomAD 0.005%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 288 of the IMPDH1 protein (p.Arg288Cys). |